This episode covers the following — since our previous deep-dive on the novel coronavirus
outbreak — including:
- practical implications for the U.S. healthcare system given how
it works today, and where we might go in the future — with CFI general
partner Julie Yoo, given our vantage point in tech; and
- how the rt-PCR test works — with CFI bio partner Judy
Savitskaya;
…in conversation with Sonal Chokshi.
Sources for updates at top:
Sources for last week’s episode:
- latest numbers: cases in the U.S. (CDC, as of February 17, 2020); global
cases (WHO situation report #25, February 14,
2020); spike in diagnosing cases as reported in China (SCMP, Scott Gottlieb)
- situation & policy statements/reports: CDC summary (as of February 14, 2020); “Annual report
on global preparedness for health emergencies”, WHO (Global Preparedness Monitoring Board,
2019)
- on definitions (of pandemics, endemics), other terms, and various naming
conventions: “Understanding pandemics: What they mean, what they
don’t mean, and what comes next with the coronavirus”, Helen Branswell, StatNews
(February 12, 2020); on disease occurrence
and levels (CDC); “misinfodemic“; best practices on naming
new human infectious diseases (WHO); qPCR (Keith Robison)
image: CDC test kit for COVID-19/ Wikimedia Commons
More From These Contributors
-
Grand Challenges in Healthcare AI with Vijay Pande and
Julie Yoo
Vijay Pande, Julie Yoo, Kris Tatiossian, and
Olivia Webb
-
Behind the Buy: Payors and Providers on AI
Adoption
Julie Yoo, Jay Rughani, Kris Tatiossian, and
Olivia Webb
-
The Most Interesting Healthcare Companies You’ve
Never Heard Of with Julie Klapstein
Julie Klapstein, Kris Tatiossian, Olivia Webb, and
Julie Yoo
-
Transitioning from Gymnast to Investor with Aly
Raisman
Aly Raisman, Kris Tatiossian, Olivia Webb, Daisy
Wolf, and Julie Yoo
-
Finding PMF in Healthcare (After Tasting it Elsewhere)
with Eren Bali and Max Cohen
Eren Bali, Max Cohen, Kris Tatiossian, Olivia
Webb, and Julie Yoo